Q32 Bio (QTTB) Income from Continuing Operations (2018 - 2025)
Historic Income from Continuing Operations for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$7.4 million.
- Q32 Bio's Income from Continuing Operations rose 5800.51% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$42.1 million, marking a year-over-year increase of 2878.75%. This contributed to the annual value of -$46.1 million for FY2024, which is 1420.65% up from last year.
- Latest data reveals that Q32 Bio reported Income from Continuing Operations of -$7.4 million as of Q3 2025, which was up 5800.51% from -$9.5 million recorded in Q2 2025.
- Q32 Bio's 5-year Income from Continuing Operations high stood at $92.7 million for Q1 2022, and its period low was -$34.6 million during Q4 2022.
- Over the past 5 years, Q32 Bio's median Income from Continuing Operations value was -$14.2 million (recorded in 2024), while the average stood at -$11.8 million.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 873588.07% in 2022, then crashed by 101543.57% in 2025.
- Q32 Bio's Income from Continuing Operations (Quarter) stood at -$33.6 million in 2021, then dropped by 2.94% to -$34.6 million in 2022, then increased by 21.33% to -$27.2 million in 2023, then surged by 47.83% to -$14.2 million in 2024, then skyrocketed by 47.92% to -$7.4 million in 2025.
- Its last three reported values are -$7.4 million in Q3 2025, -$9.5 million for Q2 2025, and -$11.0 million during Q1 2025.